Gao WH, Wang CR, Wang LN, Wan M, et al. Sequential CLAGE-Ven (cladribine, cytarabine, etoposide, and venetoclax) with
reduced-intensity conditioning improves outcomes in patients with refractory
acute myeloid leukemia: a prospective phase II study. Bone Marrow Transplant 2026 Jun 25. doi: 10.1038/s41409-026-02944.
PMID: 42350640
|